Improving Respiratory Health in Asia: A webinar
Join the RESPIRE team online to celebrate five years of RESPIRE, with a keynote presentation:
"Vaccines to prevent infant mortality from respiratory infections" from Professor Keith Klugman.
The NIHR Global Health Research Unit on Respiratory Health (RESPIRE) is an international collaboration spanning Bangladesh, India, Malaysia and Pakistan, working collaboratively with The University of Edinburgh to improve respiratory health across Asia through academic research, capacity building, and stakeholder and community engagement and involvement.
Over the last five years, RESPIRE partners have implemented 45 research studies to improve the prevention, diagnosis and management of acute and chronic respiratory diseases including pneumonia, COVID-19, asthma, and COPD. Read more: www.ed.ac.uk/usher/RESPIRE
- RESPIRE successes
- Celebrating Professor Su May Liew, and her outstanding contribution to Community Engagement & Involvement
- Keynote talk from Professor Keith Klugman
- A look to the future
Vaccines to prevent infant mortality from respiratory infections
Professor Keith Klugman | Director, Pneumonia Team, Bill & Melinda Gates Foundation
Respiratory infections remain the leading infectious cause of death of young children globally with the greatest burden among children in the poorest families. This talk will explore childhood vaccines globally including: pneumococcal conjugate vaccine (PCV), respiratory syncytial virus (RSV) vaccine developments, and maternal Group B streptococcus (GBS) vaccines.
Please note this webinar will be recorded. This work is funded by the UK National Institute for Health Research (NIHR) (Global Health Research Unit on Respiratory Health (RESPIRE); 16/136/109) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Government.